Elicio Therapeutics: Elicio and Natera To Collaborate in Phase I/II Pancreatic Cancer Study of ELI-002 – CBI
Homepage /  Press Release /  Elicio Therapeutics: Elicio and Natera To Collaborate in Phase I/II Pancreatic Cancer Study of ELI-002

Press Release

Elicio Therapeutics: Elicio and Natera To Collaborate in Phase I/II Pancreatic Cancer Study of ELI-002